Capital World Investors Buys 25,009 Shares of Corteva, Inc. $CTVA

Key Points

• Capital World Investors increased its Corteva stake by 25,009 shares in Q3 to 23,240,070 shares — about 3.44% of the company, valued at roughly $1.57 billion.
• Institutional ownership is very high at 81.54%, with big moves including Norges Bank initiating a ~$434.2M position and large increases from Pacer Advisors (+4,007.1%) and Marshall Wace (+1,365.9%).
• Corteva reported Q results with EPS of $0.22 (matched estimates) but missed revenue, set FY2026 guidance of 3.45–3.70 EPS, announced a $0.18 quarterly dividend (annualized $0.72, 0.9% yield, ex-dividend Mar 2), and insider Brian Titus sold 8,311 shares.

Capital World Investors grew its position in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 0.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 23,240,070 shares of the company's stock after purchasing an additional 25,009 shares during the period. Capital World Investors owned approximately 3.44% of Corteva worth $1,571,726,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the company. Norges Bank bought a new position in Corteva during the second quarter valued at approximately $434,220,000. Pacer Advisors Inc. increased its stake in Corteva by 4,007.1% in the 3rd quarter. Pacer Advisors Inc. now owns 2,442,177 shares of the company's stock worth $165,164,000 after acquiring an additional 2,382,715 shares during the last quarter. Marshall Wace LLP raised its holdings in shares of Corteva by 1,365.9% during the 2nd quarter. Marshall Wace LLP now owns 1,809,764 shares of the company's stock worth $134,882,000 after acquiring an additional 1,686,309 shares in the last quarter. National Pension Service boosted its position in shares of Corteva by 148.4% during the 2nd quarter. National Pension Service now owns 2,454,601 shares of the company's stock valued at $182,941,000 after acquiring an additional 1,466,268 shares during the last quarter. Finally, Qube Research & Technologies Ltd boosted its position in shares of Corteva by 566.0% during the 2nd quarter. Qube Research & Technologies Ltd now owns 1,247,120 shares of the company's stock valued at $92,948,000 after acquiring an additional 1,059,872 shares during the last quarter. 81.54% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Corteva

In other Corteva news, insider Brian Titus sold 8,311 shares of the business's stock in a transaction that occurred on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the completion of the transaction, the insider owned 8,090 shares in the company, valued at $619,289.50. The trade was a 50.67% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.15% of the stock is currently owned by insiders.

Corteva Stock Up 1.8%

Shares of CTVA opened at $78.36 on Tuesday. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The business has a fifty day moving average of $73.22 and a 200 day moving average of $69.04. The company has a market cap of $52.70 billion, a PE ratio of 49.59, a P/E/G ratio of 2.63 and a beta of 0.72. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.90.

Corteva (NYSE:CTVA - Get Free Report) last announced its earnings results on Tuesday, February 3rd. The company reported $0.22 earnings per share for the quarter, meeting the consensus estimate of $0.22. The business had revenue of $3.91 billion for the quarter, compared to the consensus estimate of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. The business's revenue for the quarter was down 1.7% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts expect that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be given a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva's dividend payout ratio is 45.57%.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. CICC Research boosted their price target on shares of Corteva from $70.00 to $80.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 11th. BNP Paribas Exane increased their price objective on shares of Corteva from $72.00 to $74.00 in a research report on Monday. Zacks Research cut shares of Corteva from a "strong-buy" rating to a "hold" rating in a research note on Friday, February 20th. Rothschild & Co Redburn decreased their target price on shares of Corteva from $71.00 to $65.00 and set a "neutral" rating on the stock in a research report on Tuesday, November 11th. Finally, The Goldman Sachs Group reaffirmed a "buy" rating and issued a $88.00 price target on shares of Corteva in a report on Thursday, February 5th. One investment analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $82.90.

About Corteva

Corteva, Inc NYSE: CTVA is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva's operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.

Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.